Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
42%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
HRTS
43
HOLDINGS
33%
ALSO IN GDOC
GDOC
39
HOLDINGS
38%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus GDOC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 7.4% | 9.7% | 7.4% |
|
ABBOTT LABORATORIES | 5.1% | 5.2% | 5.1% |
 |
ASTRAZENECA PLC | 4.4% | 4.2% | 4.2% |
|
UNITEDHEALTH GROUP INC | 4.1% | 5.2% | 4.1% |
|
BOSTON SCIENTIFIC CORP | 3.6% | 8.3% | 3.6% |
HRTS Overweight Relative to GDOC
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.3% |
|
GILEAD SCIENCES INC | 3.8% |
 |
MEDTRONIC PLC | 3.7% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
NOVARTIS AG | 3.2% |
|
BRIDGEBIO PHARMA, INC. | 3.0% |
|
AMGEN INC | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.6% |
|
CRINETICS PHARMACEUTICALS INC | 2.5% |
|
EDWARDS LIFESCIENCES CORP | 2.2% |
HRTS Underweight Relative to GDOC
|
INTUITIVE SURGICAL INC | -5.8% |
|
BOSTON SCIENTIFIC CORP | -4.7% |
|
COOPER COS INC/THE | -3.8% |
|
BIOMARIN PHARMACEUTICAL INC | -3.3% |
 |
CSL LIMITED | -3.1% |
|
LONZA GROUP AG-REG | -2.9% |
|
ABBVIE INC | -2.8% |
|
INSULET CORP | -2.7% |
|
VEEVA SYSTEMS INC-CLASS A | -2.5% |
 |
HOYA CORP | -2.5% |